首页> 外国专利> PYRROPHYRIMIDINE COMPOUNDS RELATED TO A2b-SELECTIVE ANTAGONISTS, THEIR SYNTHESIS AND APPLICATION

PYRROPHYRIMIDINE COMPOUNDS RELATED TO A2b-SELECTIVE ANTAGONISTS, THEIR SYNTHESIS AND APPLICATION

机译:与A2b选择性拮抗剂有关的焦卟啉类化合物及其合成与应用

摘要

The present invention relates to compounds of the structure where R is a substituted or unsubstituted alkyl, where the substituent is hydroxyl, dihydroxy, carboxyl, -C (= O) NRR, -NRR, -NRC (= O) NRR, -NRC (= O) OR, -OC (= O) NRR or -NHC (= O) R; R5 is hydrogen, or substituted or unsubstituted alkyl, where the substituent is hydroxyl, dihydroxy, carboxyl, -C (= O) NRR, -NRR, -NRC (= O) NRR, -NRC (= O) OR, -OC ( = O) NRR or -NHC (= O) R, or R, R and N together form a substituted piperazine, a substituted azetidine ring or a pyrrolidine ring, substituted with - (CH) OH or -CHC (= O) OH; R4 is a substituted or unsubstituted phenyl, or a 5-6 membered heteroaryl ring, where the substituent is a halogen, hydroxyl, cyano, (C-C) alkyl, (C-C) alkoxy, or -NRR; R 5 is hydrogen, or substituted or unsubstituted (C-C) alkyl; R5 is - (CH) OR, -CHNOR, -C (= O) NRR, - (CH) C (= O) OR, - (CH) C (= O) NRR; wherein R2 is a substituted or unsubstituted (C-C) alkyl, (C-C) cycloalkyl or aryl, heteroaryl or 4-8 membered heterocyclic ring; R 5 is hydrogen or substituted or unsubstituted (C-C) alkyl, (C-C) alkylaryl; each R and R independently is hydrogen or a substituted or unsubstituted (CC) alkyl, (CC) alkylaryl, (CC) alkylamino group, (CC) alkoxy group or saturated or unsaturated, monocyclic or bicyclic, carbocyclic or heterocyclic ring, or R, N and R together form substituted or unsubstituted 4-8 membered heterocyclic ring; R4 is hydrogen, or a substituted or unsubstituted (C-C) alkyl, (C-C) cycloalkyl, or aryl, heteroaryl or heterocyclic ring; R, N and R together form a 4-8 membered heterocyclic ring; each R and R independently is hydrogen or alkyl; m is 0, 1, 2 or 3; and k is 1, 2 or 3; or their specific
机译:本发明涉及具有以下结构的化合物,其中R是取代或未取代的烷基,其中取代基是羟基,二羟基,羧基,-C(= O)NRR,-NRR,-NRC(= O)NRR,-NRC( = O)OR,-OC(= O)NRR或-NHC(= O)R; R 5是氢或取代或未取代的烷基,其中取代基是羟基,二羟基,羧基,-C(= O)NRR,-NRR,-NRC(= O)NRR,-NRC(= O)OR,-OC( = O)NRR或-NHC(= O)R,或R,R和N一起形成被-(CH)OH或-CHC(= O)OH取代的取代的哌嗪,取代的氮杂环丁烷环或吡咯烷环; R4是取代或未取代的苯基,或5-6元杂芳基环,其中取代基是卤素,羟基,氰基,(C-C)烷基,(C-C)烷氧基或-NRR; R 5为氢,或取代或未取代的(C-C)烷基; R5是-(CH)OR,-CHNOR,-C(= O)NRR,-(CH)C(= O)OR,-(CH)C(= O)NRR;其中R2是取代或未取代的(C-C)烷基,(C-C)环烷基或芳基,杂芳基或4-8元杂环; R 5为氢或取代或未取代的(C-C)烷基,(C-C)烷基芳基;每个R 1和R 2独立地为氢或取代或未取代的(CC)烷基,(CC)烷基芳基,(CC)烷基氨基,(CC)烷氧基或饱和或不饱和,单环或双环,碳环或杂环,或R, N和R一起形成取代或未取代的4-8元杂环; R4是氢,或取代或未取代的(C-C)烷基,(C-C)环烷基或芳基,杂芳基或杂环; R,N和R一起形成4-8元杂环;每个R 1和R 2独立地为氢或烷基; m为0、1、2或3; k为1、2或3;或其特定

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号